However, caution is required when interpreting such results: Overall, MBC was associated with more advanced tumour staging and grade, and perhaps failure to match cases provides explanation for the increased propensity for MBC to develop RS > 30 relative to female patients with the ER-positive and HER2-negative disease. This evidence concerns the gene ESR1 and neoplasm.